LDLR and Alzheimer disease: α-mangostin:Upregulates LDLR expression.Increases cellular uptake and degradation of Aβ1–42.Enhances brain clearance of Aβ1–42.Reduces Aβ deposition.Attenuates neuroinflammatory responses.Ameliorates neurologic changes.Reverses behavioral deficits in AD model mice.